This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$4.4M
Filings
176
Firms Hired
5
Active Period
2006–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medical Device Electronic Labeling Act
2026 · third_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking
Client expense: $320,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2026 · second_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking
Client expense: $370,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2026 · first_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking
Client expense: $380,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2025 · fourth_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology Issues related to CY 2026 rulemaking
Client expense: $390,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2025 · third_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $370,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2025 · second_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $290,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Electronic Labeling Act
2025 · first_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.1539, Medical Device Electronic Labeling Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $270,000 · Firm income: —
Matched citations: H.R.1539
Medical Device Nonvisual Accessibility Act of 2023
2024 · fourth_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $260,000 · Firm income: —
Matched citations: H.R.1328
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: DEXCOM INC
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: $260,000 · Firm income: —
Matched citations: H.R.1691
Medical Device Electronic Labeling Act
2024 · fourth_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $260,000 · Firm income: —
Matched citations: H.R.3723
Medical Device Nonvisual Accessibility Act of 2023
2024 · third_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $130,000 · Firm income: —
Matched citations: H.R.1328
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: DEXCOM INC
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: $130,000 · Firm income: —
Matched citations: H.R.1691
Medical Device Electronic Labeling Act
2024 · third_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $130,000 · Firm income: —
Matched citations: H.R.3723
Medical Device Nonvisual Accessibility Act of 2023
2024 · second_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $170,000 · Firm income: —
Matched citations: H.R.1328
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: DEXCOM INC
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: $170,000 · Firm income: —
Matched citations: H.R.1691
Medical Device Electronic Labeling Act
2024 · second_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $170,000 · Firm income: —
Matched citations: H.R.3723
Medical Device Nonvisual Accessibility Act of 2023
2024 · first_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $160,000 · Firm income: —
Matched citations: H.R.1328
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · first_quarter · Firm: DEXCOM INC
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.1691
Medical Device Electronic Labeling Act
2024 · first_quarter · Firm: DEXCOM INC
CGM Coverage policy Issues related to the sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
Client expense: $160,000 · Firm income: —
Matched citations: H.R.3723
H.R.1427 - Medicare CGM Access Act of 2015 - 114th Congress (2015-2016), Administrative law and regulatory procedures / Department of Health and Human Services / Digestive and metabolic diseases / Health technology, devices, supplies / Medicare. This bill amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of continuous glucose monitoring (CGM) devices furnished to a CGM qualified individual. The Department of Health and Human Services must establish a fee schedule and ensure that CGM qualified individuals are furnished with appropriate device components.
Client expense: — · Firm income: —
Matched citations: H.R.1427
H.R.1427 - Medicare CGM Access Act of 2015 - 114th Congress (2015-2016), Administrative law and regulatory procedures / Department of Health and Human Services / Digestive and metabolic diseases / Health technology, devices, supplies / Medicare. This bill amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of continuous glucose monitoring (CGM) devices furnished to a CGM qualified individual. The Department of Health and Human Services must establish a fee schedule and ensure that CGM qualified individuals are furnished with appropriate device components.
Client expense: — · Firm income: $9,125
Matched citations: H.R.1427
Lobbied for support of H.R. 1427 and having met with Rep. David McKinley - WV, Rep. Darrell Issa - CA, Rep. Bill Huizenga - MI, Rep. Bill Johnson - OH, Rep. Candace Miller - MI, Rep. Robert Pittenger - NC, Rep. Jim Cooper - TN, Rep. Rick Crawford - AR, Rep. Kay Granger-TX, Rep. Sam Graves - GA, Rep. Ed Whitfield - KY, Rep. Culberson - TX, Rep. Jeb Hensarling - TX, and Rep. Kevin Cramer -ND.
Client expense: — · Firm income: $6,750
Matched citations: H.R. 1427
Lobbied for support of H.R. 1427 and S. 804.
Client expense: — · Firm income: $8,375
Matched citations: H.R. 1427
Lobbied for support of H.R. 1427 and S. 804.
Client expense: — · Firm income: $8,375
Matched citations: S. 804
H.R.1427 - Medicare CGM Access Act of 2015 - 114th Congress (2015-2016), Administrative law and regulatory procedures / Department of Health and Human Services / Digestive and metabolic diseases / Health technology, devices, supplies / Medicare. This bill amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of continuous glucose monitoring (CGM) devices furnished to a CGM qualified individual. The Department of Health and Human Services must establish a fee schedule and ensure that CGM qualified individuals are furnished with appropriate device components.
Client expense: — · Firm income: $25,650
Matched citations: H.R.1427
Source: Senate LDA